Literature DB >> 1554513

Epidemiology of non-intentional injuries in an Australian urban region: results from injury surveillance.

T Nolan1, M Penny.   

Abstract

Injury surveillance provides an opportunity to determine non-intentional injury rates for those injuries which are treated in hospital accident and emergency departments. The first full calendar year of injury surveillance in north-western greater Melbourne was used to calculate incidence rates of a wide range of injury types and causes for 1989. In a population at risk estimated to number 150,604 children aged 0-14 years, the all-cause injury mortality was 10.5/100,000 per year (95% confidence interval [Cl], 5.4-15.8). There were 8207 attendances by children from the denominator area for non-intentional injury at the three hospitals participating in surveillance, representing rates of 6437/100,000 per year (95% Cl, 6258-6616) and 4406/100,000 per year (95% Cl, 4254-4558) for boys and girls respectively, while the rates for admission to hospital were 957/100,000 per year (95% Cl, 888-1025) and 649/100,000 per year (95% Cl, 590-707). The leading causes of hospital attendance were related to injuries involving sports, play equipment, bicycles and poisoning. These rates are substantially lower than those reported from other countries. The possible reasons for this include differences in health care utilization, under-ascertainment of cases, and a real difference in injury risk. Injury Surveillance Information System codes are defined for a standard set of injuries and injury causes which may be used for future comparative studies. Problems related to assessing the reliability of injury ascertainment are discussed, and the importance of integrating injury surveillance into routine hospital information systems is emphasized.

Entities:  

Mesh:

Year:  1992        PMID: 1554513     DOI: 10.1111/j.1440-1754.1992.tb02613.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  16 in total

1.  Evaluation of the Latrobe Valley Better Health Injury Prevention Program.

Authors:  L M Day; J Ozanne-Smith; E Cassell; L Li
Journal:  Inj Prev       Date:  2001-03       Impact factor: 2.399

2.  Surface characteristics, equipment height, and the occurrence and severity of playground injuries.

Authors:  S Laforest; Y Robitaille; D Lesage; D Dorval
Journal:  Inj Prev       Date:  2001-03       Impact factor: 2.399

3.  Annual incidence of unintentional injury among 54,000 children.

Authors:  S S Walsh; S N Jarvis; E M Towner; A Aynsley-Green
Journal:  Inj Prev       Date:  1996-03       Impact factor: 2.399

4.  Head injuries in helmeted child bicyclists.

Authors:  G Grimard; T Nolan; J B Carlin
Journal:  Inj Prev       Date:  1995-03       Impact factor: 2.399

Review 5.  Quantifying the risk of sports injury: a systematic review of activity-specific rates for children under 16 years of age.

Authors:  Anneliese B Spinks; Roderick J McClure
Journal:  Br J Sports Med       Date:  2007-05-01       Impact factor: 13.800

6.  Injury risk from popular childhood physical activities: results from an Australian primary school cohort.

Authors:  A B Spinks; A K Macpherson; C Bain; R J McClure
Journal:  Inj Prev       Date:  2006-12       Impact factor: 2.399

7.  Injury management by GPs in Australia.

Authors:  R J McClure; J Ozanne-Smith
Journal:  Br J Gen Pract       Date:  1996-01       Impact factor: 5.386

8.  Reduction in paediatric burn admissions over 25 years, 1970-94.

Authors:  C Streeton; T Nolan
Journal:  Inj Prev       Date:  1997-06       Impact factor: 2.399

9.  The epidemiology and causes of injuries resulting in hospitalization in New York City: 1990-1992.

Authors:  P E Bijur; S Wilt; M Kurzon; R Hayes; A Goodman
Journal:  Bull N Y Acad Med       Date:  1997

Review 10.  A review of injury epidemiology in the UK and Europe: some methodological considerations in constructing rates.

Authors:  Roxana Alexandrescu; Sarah J O'Brien; Fiona E Lecky
Journal:  BMC Public Health       Date:  2009-07-10       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.